VACcination In Methotrexate Treated Rheumatoid Arthritis Patients

NCT01942174 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

276

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Prevenar 13
BIOLOGICAL: Pneumo23 / Pneumovax
DRUG: Methotrexate - Immediate
DRUG: Methotrexate - Delay

Sponsor

University Hospital, Montpellier

Collaborators

[object Object]
[object Object]